A recent independent study reached a similar conclusion: adding abemaciclib converted a partially active RT + aPD-L1 doublet into a markedly effective triplet by further inflaming the tumor microenvironment and enhancing CD8+ infiltration [63]. Here, CD8A is linked to neoplasm.